Media Center Found (709)
Array ( [cache_time] => 0 [counts_time] => 0.0071289539337158 [query_time] => 0.005075216293335 [total_time] => 0.012204170227051 )
December 10, 2007

The Israeli company is developing treatments for various neurological diseases based on a technology licensed from Yissum

More
December 8, 2007

One of Israel's leading biochemists, Prof. Yechezkel Barenholz of the Hebrew University's Hadassah Medical School, has used liposomes to design better drug delivery systems that extend and improve the lives of cancer patients around the...

More
December 2, 2007

US-Israeli biopharmaceutical start-up Medgenics Inc. raised a gross ₤3.3 million in its IPO on London’s Alternative Investment Market (AIM) on Thursday at a company value of ₤10.4 million, after money. The company, which is based on Yissum's...

More
November 26, 2007

People call what Target-In is doing 'guided missiles', and in a way that's exactly what the company's technology is: a guided missile that can recognize and kill inflamed cells from tumors and other diseases. But Target-In's technology is more...

More
November 15, 2007

BioLineRx today announced that it has signed a worldwide exclusive

license agreement with Yissum, the technology transfer company of the Hebrew University of Jerusalem, and Hadasit, the technology transfer company of Hadassah medical...

More
November 7, 2007

Indian API company Century Pharmaceutical has already promised to invest $1 million.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 1, 2007

Various projects in the water, cleantech and alternative energy fields were presented by Yissum at the Watec 2007exhibition, October 30-31, Tel Aviv

More
October 29, 2007

Prof. Nathan Citri of the Hebrew University of Jerusalem invented a kit for the rapid detection of anthrax.

More
October 29, 2007

Hebrew University Prof. Joseph Almog developed a kit for the detection of Urea Nitrate  (Hebrew Article)

More
October 28, 2007

A research group headed by Hebrew University Professor Aaron Kaplan found a solution to the growing problem of toxic algae

More
October 25, 2007

The research, patented by Yissum,  could lead to a new class of antibiotics

More
October 15, 2007

The company first plans to raise several million dollars in a private placement.

More